Hypertension: all 6,834 studies

Page 65 of 69. Open to participants first (971), then studies with results posted, then the rest; newest registration first within each.

• Blood Pressure Lowering Effects of Grape JuiceCompletedNCT00302809Not applicable
• Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One DoseCompletedNCT00302705Phase 4
• The STRETCH Study: Distensibility on Endothelial-Dependent Vasoreactivity in Subjects With Systolic HypertensionCompletedNCT00302250Phase 2
• Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular HypertensionCompletedNCT00300443Phase 2/3
• Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular HypertensionCompletedNCT00300079Phase 4
• SPP100 (Aliskiren) Regimen in Hypertensive Patients With Renal DysfunctionCompletedNCT00299832Phase 3
• SPP100 (Aliskiren) Regimen in Patients With Severe HypertensionCompletedNCT00299806Phase 3
• The Effect of the Patient Activation Measure on Chronic CareCompletedNCT00299468Phase 1
• Walking Intervention in African American Adults With Newly Diagnosed HypertensionCompletedNCT00298207Not applicable
• Cardiovascular Risk Assessment in Patients Treated With CaduetCompletedNCT00297973Phase 4
• Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic NephropathyCompletedNCT00295555Phase 4
• Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of ChronotherapyCompletedNCT00295542Phase 4
• A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of AmlodipineCompletedNCT00294710Phase 3
• Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)CompletedNCT00294567Phase 4
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00293800Phase 3
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00293787Phase 3
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00293761Phase 3
• Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia TrialWithdrawnNCT00293735Phase 2/3
• Efficacy and Safety Study of S-Amlodipine Gentisate Compared to Amlodipine Besylate to Treat Mild-to-Moderate HypertensionCompletedNCT00289406Phase 3
• Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension PatientsCompletedNCT00288951Phase 3
• Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese PatientsStatus unknownNCT00288717Not applicable
• Uric Acid in Essential Hypertension in ChildrenCompletedNCT00288184Phase 2
• Allopurinol for Renal Transplant Associated Hypertension in ChildrenWithdrawnNCT00288171Phase 1/2
• Primary Prevention of Hypertension in Obese AdolescentsCompletedNCT00288158Phase 2
• A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00287521Phase 2
• Heart Rate Variability in White Coat Hypertension and Essential HypertensionCompletedNCT00286884
• Japan Morning Surge-1 StudyCompletedNCT00285519Phase 4
• AVE7688 in Patients With Mild to Moderate Blood PressureCompletedNCT00284128Phase 2/3
• Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery DeviceWithdrawnNCT00283764Phase 3
• APROVE : Irbesartan in HypertensionCompletedNCT00283036Phase 4
• The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose ControlCompletedNCT00282659Phase 4
• Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and PlaceboCompletedNCT00282178Phase 2
• Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of HypertensionCompletedNCT00281593Phase 3
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With HypertensionCompletedNCT00280540Phase 4
• A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With GlaucomaCompletedNCT00277498Phase 3
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With HypertensionCompletedNCT00277472Phase 4
• Improving Adherence in Patients With Hypertension - A Novel Use of Communication TechnologyCompletedNCT00277381Not applicable
• PROBE Parallel 6-week Treatment Comparing Telmisartan/Hydrochlorothiazide (HCT) (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using Ambulatory Blood Pressure Monitoring (ABPM)CompletedNCT00274638Phase 4
• Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPMCompletedNCT00274612Phase 4
• PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTNCompletedNCT00274599Phase 4
• DETAIL Study: Diabetes Exposed to Telmisartan and EnalaprilCompletedNCT00274118Phase 3
• Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe HypertensionCompletedNCT00273299Phase 3
• Hydroxyurea and Erythropoietin to Treat Sickle Cell AnemiaCompletedNCT00270478Phase 1
• Conditioned Placebo Effects and Treatment of HypertensionCompletedNCT00269269Phase 2
• Open-label Follow-up Trial of Fixed Dose Combination of Telmisartan + Hydrochlorothiazide in Hypertensive PatientsCompletedNCT00267943Phase 3
• Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled HypertensionCompletedNCT00267176Phase 4
• Bosentan in Treatment of Pulmonary Arterial HypertensionCompletedNCT00266162Phase 4
• Irbesartan in HypertensionCompletedNCT00265967Phase 4
• Evaluation of a New Blood Pressure Measuring Device.Status unknownNCT00265707Not applicable
• Improving Practice Patterns for the Treatment of HypertensionCompletedNCT00265044Not applicable
• AMISH : Aprovel for Management of Isolated Systolic HypertensionCompletedNCT00264212Phase 4
• Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate HypertensionCompletedNCT00263003Phase 3
• Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate HypertensionCompletedNCT00262236Phase 3
• A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren in Patients With High Blood PressureCompletedNCT00260923Phase 3
• Progression Evaluation and Genetic Determinants of Hypertension in Chinese - A Follow-up Study of Taiwan SAPPHIReCompletedNCT00260910
• Effects of Bosentan (Tracleer) in the Course of Pulmonary Artery Hypertension Induced by HypoxiaCompletedNCT00260819Phase 1
• Dialysate Sodium Individualization in HemodialysisTerminatedNCT00259714Phase 1
• RIAT Registry: Reason for Not Intensifying Antihypertensive TreatmentCompletedNCT00258921
• Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential HypertensionCompletedNCT00257491Phase 3
• Safety and Efficacy Study of Transplantation of EPCs to Treat Idiopathic Pulmonary Arterial HypertensionCompletedNCT00257413Not applicable
• Dose Ranging, Safety and Tolerability of TOPROL-XL® Extended-Release Tablets in Hypertensive Pediatric SubjectsCompletedNCT00255528Phase 3
• 307B - Safety, Tolerability and Pharmacokinetics Study of TOPROL-XL® in Hypertensive Pediatric SubjectsCompletedNCT00255502Phase 3
• A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and HypercholesterolemiaCompletedNCT00254475Phase 3
• Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis CCompletedNCT00252642Not applicable
• Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 YearsCompletedNCT00250640
• A Study in Chinese Mild to Moderate Hypertensive Patients Comparing the Efficacy of Co-Diovan With Diovan.CompletedNCT00250562Phase 3
• A Pilot Study of Changing Medication Adherence In Hypertensive African-American PatientsCompletedNCT00248937Not applicable
• A Randomized Trial of Changing Medication Adherence In Hypertensive African-American PatientsCompletedNCT00248872Not applicable
• Behavioural Treatment of HypertensionCompletedNCT00247910Not applicable
• A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)CompletedNCT00246584Phase 2
• Blood Pressure Reduction in Danish General Practice (BRIDGE)CompletedNCT00244660Phase 4
• Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of AgeCompletedNCT00244634Phase 3
• Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of AgeCompletedNCT00244595Phase 3
• Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic SyndromeCompletedNCT00241150Phase 4
• A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 MgCompletedNCT00241137Phase 3
• Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With DiabetesCompletedNCT00241124Phase 4
• The VALIDATE Study of Valsartan for Patients With Early Stage Heart FailureCompletedNCT00241098Phase 4
• Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes MellitusCompletedNCT00241085Phase 4
• A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With HypertensionCompletedNCT00241007Phase 3
• Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial HypertensionCompletedNCT00240656Phase 1
• A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)CompletedNCT00240474Phase 4
• A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II PatientsCompletedNCT00240448Phase 4
• SMOOTH - Blood Pressure Control in Diabetic/Obese PatientsCompletedNCT00239538Phase 4
• 3-D Transcranial Ultrasound Analysis StudyCompletedNCT00239525Not applicable
• Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5CompletedNCT00239369Phase 3
• Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)CompletedNCT00237588Phase 4
• A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential HypertensionCompletedNCT00236665Phase 3
• Iloprost-Study: Comparison of Nitric Oxide to Iloprost (Ventavis) for Treatment of Pulmonary Hypertension in Children After Cardiopulmonary Bypass SurgeryCompletedNCT00235521Not applicable
• A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)CompletedNCT00235014Phase 4
• Russian Study of the Efficacy and Safety of Tarka in Patients With HypertensionCompletedNCT00235001Phase 4
• Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)CompletedNCT00234871Phase 4
• Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)CompletedNCT00234858Phase 4
• Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)CompletedNCT00233532Phase 4
• Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.CompletedNCT00232882Phase 4
• Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular PressureCompletedNCT00230763Phase 3
• Comparison of Diuretic-based With Non-diuretic Based Hypertension Therapy Using Echocardiographic MeasuresCompletedNCT00229242Not applicable
• Induced Hypertension for Acute Ischemic StrokeCompletedNCT00227448Phase 2
• TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention TrialCompletedNCT00227318Phase 3
• The Association Between the Use of Complementary and Alternative Medicine and Medication Adherence in Hypertensive African-AmericansCompletedNCT00227201
• Cornell Translational Behavioral Science Research Consortium: Hypertension Qualitative StudyCompletedNCT00227175

← Hypertension overview